Yoo J, Walker-Dilks C.
PET imaging in head and neck cancer: recommendations.
Cancer Care Ontario (CCO); 2009 Jan 19. 43 p. NGC

PET for Head and Neck Cancer . MSAC. 2009.

Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP.  
18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. 
Journal of the National Cancer Institute 2008; 100(10): 712-720SIGN.DARE. Pubmed.

FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best: a systematic review. Liu T, Xu W, Yan W L, Ye M, Bai Y R, Huang G . Radiotherapy and  Oncology 2007; 85(3): 327-335. DARE.

Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. National Coordinating Centre for Health Technology Assessment. 2007. HTA .

Positron emission tomography (PET) - diagnostic and clinical use (En Noruego). The Norwegian Centre for Health Technology Assessment . HTA . 2003.

Uso tutelado de la Tomografía por Emisión de Positrones (PET) con 18FDG. Agencia de Evaluacion de Tecnologias Sanitarias (AETS). 2005. HTA.

Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. Delgado-Bolton R C, Fernandez-Perez C, Gonzalez-Mate A, Carreras J L. Journal of Nuclear Medicine, 2003;44(8):1301-1314. DARE.

PET-TAC: Indicaciones, revisión sistemática y meta-análisis.  Agencia de Evaluacion de Tecnologias Sanitarias (AETS). ISCIII. 2004.

Assessment of clinical utility of F-18-FDG PET in patients with head and neck cancer: a probability analysis. Goerres G W, Mosna-Firlejczyk K, Steurer J, von Schulthess G K, Bachmann L M. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30(4):562-571. DARE.

Health technology assessment of PET (positron emission tomography). Institute for Clinical Evaluative Sciences (ICES). 2001. HTA.

Health technology assessment of positron emission tomography in oncology - a systematic review (Update Septiembre,2003). Institute for Clinical Evaluative Sciences (ICES). 2003. HTA.

Positron Emission Tomography (PET) - additional indications. MSAC. 2001

Tomographie par emission de positons. English. CEDIT.  2001 

Tomografíaa por Emisión de Positrones con 18FDG en oncología clínica. Revisión sistemática. Agencia de Evaluacion de Tecnologias Sanitarias (AETS). 2001.

Tomografía por emisión de positrones, PET, en oncología clínica no neurológica. AETS. 1997.

Positron Emission Tomography. Proyecto INAHTA. OSTEBA.1999.

Positron emision tomography: establishing priorities for health technology assessment: a review. NCCHTA. 1999